These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 17507469)

  • 21. Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding.
    Triyatni M; Vergalla J; Davis AR; Hadlock KG; Foung SK; Liang TJ
    Virology; 2002 Jun; 298(1):124-32. PubMed ID: 12093180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virus-neutralizing antibodies to hepatitis C virus.
    Wahid A; Dubuisson J
    J Viral Hepat; 2013 Jun; 20(6):369-76. PubMed ID: 23647953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct roles in folding, CD81 receptor binding and viral entry for conserved histidine residues of hepatitis C virus glycoprotein E1 and E2.
    Boo I; teWierik K; Douam F; Lavillette D; Poumbourios P; Drummer HE
    Biochem J; 2012 Apr; 443(1):85-94. PubMed ID: 22240035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD81 is an entry coreceptor for hepatitis C virus.
    Cormier EG; Tsamis F; Kajumo F; Durso RJ; Gardner JP; Dragic T
    Proc Natl Acad Sci U S A; 2004 May; 101(19):7270-4. PubMed ID: 15123813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors.
    Bitzegeio J; Bankwitz D; Hueging K; Haid S; Brohm C; Zeisel MB; Herrmann E; Iken M; Ott M; Baumert TF; Pietschmann T
    PLoS Pathog; 2010 Jul; 6(7):e1000978. PubMed ID: 20617177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner.
    McKeating JA; Zhang LQ; Logvinoff C; Flint M; Zhang J; Yu J; Butera D; Ho DD; Dustin LB; Rice CM; Balfe P
    J Virol; 2004 Aug; 78(16):8496-505. PubMed ID: 15280458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion.
    Falson P; Bartosch B; Alsaleh K; Tews BA; Loquet A; Ciczora Y; Riva L; Montigny C; Montpellier C; Duverlie G; Pécheur EI; le Maire M; Cosset FL; Dubuisson J; Penin F
    J Virol; 2015 Oct; 89(20):10333-46. PubMed ID: 26246575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus envelope glycoprotein signatures are associated with treatment failure and modulation of viral entry and neutralization.
    Schvoerer E; Moenne-Loccoz R; Murray JM; Velay A; Turek M; Fofana I; Fafi-Kremer S; Erba AC; Habersetzer F; Doffoël M; Gut JP; Donlin MJ; Tavis JE; Zeisel MB; Stoll-Keller F; Baumert TF
    J Infect Dis; 2013 Apr; 207(8):1306-15. PubMed ID: 23335805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of a conserved RGE/RGD motif in HCV E2 in mediating entry.
    Rothwangl KB; Rong L
    Virol J; 2009 Jan; 6():12. PubMed ID: 19171049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans.
    Helle F; Wychowski C; Vu-Dac N; Gustafson KR; Voisset C; Dubuisson J
    J Biol Chem; 2006 Sep; 281(35):25177-83. PubMed ID: 16809348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus E2 has three immunogenic domains containing conformational epitopes with distinct properties and biological functions.
    Keck ZY; Op De Beeck A; Hadlock KG; Xia J; Li TK; Dubuisson J; Foung SK
    J Virol; 2004 Sep; 78(17):9224-32. PubMed ID: 15308717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of hepatitis C virus envelope proteins with exosomes.
    Masciopinto F; Giovani C; Campagnoli S; Galli-Stampino L; Colombatto P; Brunetto M; Yen TS; Houghton M; Pileri P; Abrignani S
    Eur J Immunol; 2004 Oct; 34(10):2834-42. PubMed ID: 15368299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C virus envelope protein E2 binds to CD81 of tamarins.
    Allander T; Forns X; Emerson SU; Purcell RH; Bukh J
    Virology; 2000 Nov; 277(2):358-67. PubMed ID: 11080483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations.
    Krieger SE; Zeisel MB; Davis C; Thumann C; Harris HJ; Schnober EK; Mee C; Soulier E; Royer C; Lambotin M; Grunert F; Dao Thi VL; Dreux M; Cosset FL; McKeating JA; Schuster C; Baumert TF
    Hepatology; 2010 Apr; 51(4):1144-57. PubMed ID: 20069648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional expression and characterization of the envelope glycoprotein E1E2 heterodimer of hepatitis C virus.
    Cao L; Yu B; Kong D; Cong Q; Yu T; Chen Z; Hu Z; Chang H; Zhong J; Baker D; He Y
    PLoS Pathog; 2019 May; 15(5):e1007759. PubMed ID: 31116791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81.
    Zeisel MB; Koutsoudakis G; Schnober EK; Haberstroh A; Blum HE; Cosset FL; Wakita T; Jaeck D; Doffoel M; Royer C; Soulier E; Schvoerer E; Schuster C; Stoll-Keller F; Bartenschlager R; Pietschmann T; Barth H; Baumert TF
    Hepatology; 2007 Dec; 46(6):1722-31. PubMed ID: 18000990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A protein coevolution method uncovers critical features of the Hepatitis C Virus fusion mechanism.
    Douam F; Fusil F; Enguehard M; Dib L; Nadalin F; Schwaller L; Hrebikova G; Mancip J; Mailly L; Montserret R; Ding Q; Maisse C; Carlot E; Xu K; Verhoeyen E; Baumert TF; Ploss A; Carbone A; Cosset FL; Lavillette D
    PLoS Pathog; 2018 Mar; 14(3):e1006908. PubMed ID: 29505618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mathematical model of viral kinetics in vitro estimates the number of E2-CD81 complexes necessary for hepatitis C virus entry.
    Padmanabhan P; Dixit NM
    PLoS Comput Biol; 2011 Dec; 7(12):e1002307. PubMed ID: 22174670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive functional analysis of N-linked glycans on Ebola virus GP1.
    Lennemann NJ; Rhein BA; Ndungo E; Chandran K; Qiu X; Maury W
    mBio; 2014 Jan; 5(1):e00862-13. PubMed ID: 24473128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential interaction strategies of hepatitis c virus genotypes during entry - An in silico investigation of envelope glycoprotein E2 - CD81 interaction.
    Bhattacharjee C; Nandy SK; Das P; Mukhopadhyay A
    Infect Genet Evol; 2019 Apr; 69():48-60. PubMed ID: 30639544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.